The global market for Pertussis Vaccine was estimated to be worth US$ 5187.9 million in 2023 and is forecast to a readjusted size of US$ 6619.4 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030

Pertussis Vaccine - Market

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pertussis Vaccine by region & country, by Type, and by Application.

The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.

Market Segmentation

Scope of Pertussis Vaccine - Market Report

Report Metric	Details
Report Name	Pertussis Vaccine - Market
Forecasted market size in 2030	US$ 6619.4 million
CAGR	3.5%
Forecasted years	2024 - 2030
Segment by Type:	Whole-cell Vaccines Acellular Vaccines
Segment by Application	12 Months Below 12 Months Above
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics, Chengdu Institute of Biological Products
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pertussis Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Pertussis Vaccine - Market size in 2030?

Ans: The Pertussis Vaccine - Market size in 2030 will be US$ 6619.4 million.

What is the market share of major companies in Pertussis Vaccine - Market?

Ans: Global top 2 manufacturers hold a share about 90%.

Who are the main players in the Pertussis Vaccine - Market report?

Ans: The main players in the Pertussis Vaccine - Market are Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics, Chengdu Institute of Biological Products

What are the Application segmentation covered in the Pertussis Vaccine - Market report?

Ans: The Applications covered in the Pertussis Vaccine - Market report are 12 Months Below, 12 Months Above

What are the Type segmentation covered in the Pertussis Vaccine - Market report?

Ans: The Types covered in the Pertussis Vaccine - Market report are Whole-cell Vaccines, Acellular Vaccines

1 Market Overview

1.1 Pertussis Vaccine Product Introduction

1.2 Global Pertussis Vaccine Market Size Forecast

1.2.1 Global Pertussis Vaccine Sales Value (2019-2030)

1.2.2 Global Pertussis Vaccine Sales Volume (2019-2030)

1.2.3 Global Pertussis Vaccine Sales Price (2019-2030)

1.3 Pertussis Vaccine Market Trends & Drivers

1.3.1 Pertussis Vaccine Industry Trends

1.3.2 Pertussis Vaccine Market Drivers & Opportunity

1.3.3 Pertussis Vaccine Market Challenges

1.3.4 Pertussis Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pertussis Vaccine Players Revenue Ranking (2023)

2.2 Global Pertussis Vaccine Revenue by Company (2019-2024)

2.3 Global Pertussis Vaccine Players Sales Volume Ranking (2023)

2.4 Global Pertussis Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Pertussis Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Pertussis Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Pertussis Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Pertussis Vaccine

2.9 Pertussis Vaccine Market Competitive Analysis

2.9.1 Pertussis Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Pertussis Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Whole-cell Vaccines

3.1.2 Acellular Vaccines

3.2 Global Pertussis Vaccine Sales Value by Type

3.2.1 Global Pertussis Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Pertussis Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Pertussis Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Pertussis Vaccine Sales Volume by Type

3.3.1 Global Pertussis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Pertussis Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Pertussis Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Pertussis Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 12 Months Below

4.1.2 12 Months Above

4.2 Global Pertussis Vaccine Sales Value by Application

4.2.1 Global Pertussis Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Pertussis Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Pertussis Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Pertussis Vaccine Sales Volume by Application

4.3.1 Global Pertussis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Pertussis Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Pertussis Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Pertussis Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Pertussis Vaccine Sales Value by Region

5.1.1 Global Pertussis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Pertussis Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Pertussis Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Pertussis Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Pertussis Vaccine Sales Volume by Region

5.2.1 Global Pertussis Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Pertussis Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Pertussis Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Pertussis Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Pertussis Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Pertussis Vaccine Sales Value, 2019-2030

5.4.2 North America Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Pertussis Vaccine Sales Value, 2019-2030

5.5.2 Europe Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Pertussis Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Pertussis Vaccine Sales Value, 2019-2030

5.7.2 South America Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Pertussis Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pertussis Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Pertussis Vaccine Sales Value

6.2.1 Key Countries/Regions Pertussis Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Pertussis Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Pertussis Vaccine Sales Value, 2019-2030

6.3.2 United States Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Pertussis Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Pertussis Vaccine Sales Value, 2019-2030

6.4.2 Europe Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Pertussis Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Pertussis Vaccine Sales Value, 2019-2030

6.5.2 China Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Pertussis Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Pertussis Vaccine Sales Value, 2019-2030

6.6.2 Japan Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Pertussis Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Pertussis Vaccine Sales Value, 2019-2030

6.7.2 South Korea Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Pertussis Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Pertussis Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Pertussis Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Pertussis Vaccine Sales Value, 2019-2030

6.9.2 India Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Pertussis Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi Pasteur

7.1.1 Sanofi Pasteur Company Information

7.1.2 Sanofi Pasteur Introduction and Business Overview

7.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Pasteur Pertussis Vaccine Product Offerings

7.1.5 Sanofi Pasteur Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Pertussis Vaccine Product Offerings

7.2.5 GSK Recent Development

7.3 Mitsubishi Tanabe Pharma

7.3.1 Mitsubishi Tanabe Pharma Company Information

7.3.2 Mitsubishi Tanabe Pharma Introduction and Business Overview

7.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Offerings

7.3.5 Mitsubishi Tanabe Pharma Recent Development

7.4 Wuhan Institute of Biological Products

7.4.1 Wuhan Institute of Biological Products Company Information

7.4.2 Wuhan Institute of Biological Products Introduction and Business Overview

7.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Offerings

7.4.5 Wuhan Institute of Biological Products Recent Development

7.5 Walvax Biotechnology

7.5.1 Walvax Biotechnology Company Information

7.5.2 Walvax Biotechnology Introduction and Business Overview

7.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Walvax Biotechnology Pertussis Vaccine Product Offerings

7.5.5 Walvax Biotechnology Recent Development

7.6 Minhai Biotechnology

7.6.1 Minhai Biotechnology Company Information

7.6.2 Minhai Biotechnology Introduction and Business Overview

7.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Minhai Biotechnology Pertussis Vaccine Product Offerings

7.6.5 Minhai Biotechnology Recent Development

7.7 KM Biologics

7.7.1 KM Biologics Company Information

7.7.2 KM Biologics Introduction and Business Overview

7.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 KM Biologics Pertussis Vaccine Product Offerings

7.7.5 KM Biologics Recent Development

7.8 Chengdu Institute of Biological Products

7.8.1 Chengdu Institute of Biological Products Company Information

7.8.2 Chengdu Institute of Biological Products Introduction and Business Overview

7.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Offerings

7.8.5 Chengdu Institute of Biological Products Recent Development

8 Industry Chain Analysis

8.1 Pertussis Vaccine Industrial Chain

8.2 Pertussis Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Pertussis Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Pertussis Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur

GSK

Wuhan Institute of Biological Products

Mitsubishi Tanabe Pharma

Walvax Biotechnology

Minhai Biotechnology

KM Biologics

Chengdu Institute of Biological Products

List of Tables

Table 1. Pertussis Vaccine Market Trends

Table 2. Pertussis Vaccine Market Drivers & Opportunity

Table 3. Pertussis Vaccine Market Challenges

Table 4. Pertussis Vaccine Market Restraints

Table 5. Global Pertussis Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Pertussis Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Pertussis Vaccine Sales Volume by Company (2019-2024) & (M Doses)

Table 8. Global Pertussis Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Pertussis Vaccine Price by Company (2019-2024) & (USD/Doses)

Table 10. Key Manufacturers Pertussis Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Pertussis Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Pertussis Vaccine

Table 13. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Pertussis Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Pertussis Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Pertussis Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Pertussis Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Pertussis Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Pertussis Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (M Doses)

Table 22. Global Pertussis Vaccine Sales Volume by Type (2019-2024) & (M Doses)

Table 23. Global Pertussis Vaccine Sales Volume by Type (2025-2030) & (M Doses)

Table 24. Global Pertussis Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Pertussis Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Pertussis Vaccine Price by Type (2019-2024) & (USD/Doses)

Table 27. Global Pertussis Vaccine Price by Type (2025-2030) & (USD/Doses)

Table 28. Global Pertussis Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Pertussis Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Pertussis Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Pertussis Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Pertussis Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Pertussis Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (M Doses)

Table 34. Global Pertussis Vaccine Sales Volume by Application (2019-2024) & (M Doses)

Table 35. Global Pertussis Vaccine Sales Volume by Application (2025-2030) & (M Doses)

Table 36. Global Pertussis Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Pertussis Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Pertussis Vaccine Price by Application (2019-2024) & (USD/Doses)

Table 39. Global Pertussis Vaccine Price by Application (2025-2030) & (USD/Doses)

Table 40. Global Pertussis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Pertussis Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Pertussis Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Pertussis Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Pertussis Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Pertussis Vaccine Sales Volume by Region (M Doses): 2019 VS 2023 VS 2030

Table 46. Global Pertussis Vaccine Sales Volume by Region (2019-2024) & (M Doses)

Table 47. Global Pertussis Vaccine Sales Volume by Region (2025-2030) & (M Doses)

Table 48. Global Pertussis Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Pertussis Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Pertussis Vaccine Average Price by Region (2019-2024) & (USD/Doses)

Table 51. Global Pertussis Vaccine Average Price by Region (2025-2030) & (USD/Doses)

Table 52. Key Countries/Regions Pertussis Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Pertussis Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Pertussis Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Pertussis Vaccine Sales Volume, (2019-2024) & (M Doses)

Table 56. Key Countries/Regions Pertussis Vaccine Sales Volume, (2025-2030) & (M Doses)

Table 57. Sanofi Pasteur Company Information

Table 58. Sanofi Pasteur Introduction and Business Overview

Table 59. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 60. Sanofi Pasteur Pertussis Vaccine Product Offerings

Table 61. Sanofi Pasteur Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 65. GSK Pertussis Vaccine Product Offerings

Table 66. GSK Recent Development

Table 67. Mitsubishi Tanabe Pharma Company Information

Table 68. Mitsubishi Tanabe Pharma Introduction and Business Overview

Table 69. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 70. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Offerings

Table 71. Mitsubishi Tanabe Pharma Recent Development

Table 72. Wuhan Institute of Biological Products Company Information

Table 73. Wuhan Institute of Biological Products Introduction and Business Overview

Table 74. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 75. Wuhan Institute of Biological Products Pertussis Vaccine Product Offerings

Table 76. Wuhan Institute of Biological Products Recent Development

Table 77. Walvax Biotechnology Company Information

Table 78. Walvax Biotechnology Introduction and Business Overview

Table 79. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 80. Walvax Biotechnology Pertussis Vaccine Product Offerings

Table 81. Walvax Biotechnology Recent Development

Table 82. Minhai Biotechnology Company Information

Table 83. Minhai Biotechnology Introduction and Business Overview

Table 84. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 85. Minhai Biotechnology Pertussis Vaccine Product Offerings

Table 86. Minhai Biotechnology Recent Development

Table 87. KM Biologics Company Information

Table 88. KM Biologics Introduction and Business Overview

Table 89. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 90. KM Biologics Pertussis Vaccine Product Offerings

Table 91. KM Biologics Recent Development

Table 92. Chengdu Institute of Biological Products Company Information

Table 93. Chengdu Institute of Biological Products Introduction and Business Overview

Table 94. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 95. Chengdu Institute of Biological Products Pertussis Vaccine Product Offerings

Table 96. Chengdu Institute of Biological Products Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Pertussis Vaccine Downstream Customers

Table 100. Pertussis Vaccine Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Pertussis Vaccine Product Picture

Figure 2. Global Pertussis Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Pertussis Vaccine Sales Volume (2019-2030) & (M Doses)

Figure 5. Global Pertussis Vaccine Sales Price (2019-2030) & (USD/Doses)

Figure 6. Pertussis Vaccine Report Years Considered

Figure 7. Global Pertussis Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Pertussis Vaccine Players Sales Volume Ranking (2023) & (M Doses)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pertussis Vaccine Revenue in 2023

Figure 10. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Whole-cell Vaccines Picture

Figure 12. Acellular Vaccines Picture

Figure 13. Global Pertussis Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Pertussis Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Pertussis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)

Figure 16. Global Pertussis Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Pertussis Vaccine Price by Type (2019-2030) & (USD/Doses)

Figure 18. Product Picture of 12 Months Below

Figure 19. Product Picture of 12 Months Above

Figure 20. Global Pertussis Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Pertussis Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Pertussis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)

Figure 23. Global Pertussis Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Pertussis Vaccine Price by Application (2019-2030) & (USD/Doses)

Figure 25. North America Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Pertussis Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Pertussis Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Pertussis Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Pertussis Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Pertussis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Pertussis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Pertussis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Pertussis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Pertussis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Pertussis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Pertussis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Pertussis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Pertussis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Pertussis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Pertussis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Pertussis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Pertussis Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Pertussis Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Pertussis Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Pertussis Vaccine Industrial Chain

Figure 59. Pertussis Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions